Cargando…
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644788/ https://www.ncbi.nlm.nih.gov/pubmed/38023128 http://dx.doi.org/10.3389/fonc.2023.1272856 |
_version_ | 1785134624150650880 |
---|---|
author | Mione, Cécile Casile, Mélanie Moreau, Juliette Miroir, Jessica Molnar, Ioana Chautard, Emmanuel Bernadach, Maureen Kossai, Myriam Saroul, Nicolas Martin, F. Pham-Dang, Nathalie Lapeyre, Michel Biau, Julian |
author_facet | Mione, Cécile Casile, Mélanie Moreau, Juliette Miroir, Jessica Molnar, Ioana Chautard, Emmanuel Bernadach, Maureen Kossai, Myriam Saroul, Nicolas Martin, F. Pham-Dang, Nathalie Lapeyre, Michel Biau, Julian |
author_sort | Mione, Cécile |
collection | PubMed |
description | BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focus on loco-regional patterns of failure. MATERIAL AND METHODS: Between 2011 and 2019, 167 patients were included (40% of oropharyngeal cancers, and 60% of oral cavity cancers). The median age was 60 years. There was 64.2% of stage IV cancers. All patients had both T and N surgery. 34% had a R1 margin, 42% had perineural invasion. 72% had a positive neck dissection and 42% extranodal extension (ENE). All patients were treated with VMAT with simultaneous integrated boost with three dose levels: 66Gy in case of R1 margin and/or ENE, 59.4-60Gy on the tumor bed, and 54Gy on the prophylactic areas. Concomittant cisplatin was administrated concomitantly when feasible in case of R1 and/or ENE. RESULTS: The 1- and 2-year loco-regional control rates were 88.6% and 85.6% respectively. Higher tumor stage (T3/T4), the presence of PNI, and time from surgery >45 days were significant predictive factors of worse loco-regional control in multivariate analysis (p=0.02, p=0.04, and p=0.02). There were 17 local recurrences: 11 (64%) were considered as infield, 4 (24%) as marginal, and 2 (12%) as outfield. There were 9 regional recurrences only, 8 (89%) were considered as infield, and 1 (11%) as outfield. The 1- and 2-year disease-free survival (DFS) rates were 78.9% and 71.8% respectively. The 1- and 2-year overall survival (OS) rates were 88.6% and 80% respectively. Higher tumor stage (T3/T4) and the presence of ENE were the two prognostic factors significantly associated with worse DFS and OS in multivariate analysis. CONCLUSION: Our outcomes for postoperative VMAT for oral cavity and oropharyngeal cancers are encouraging, with high rates of loco-regional control. However, the management of ENE still seems challenging. |
format | Online Article Text |
id | pubmed-10644788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106447882023-01-01 Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy Mione, Cécile Casile, Mélanie Moreau, Juliette Miroir, Jessica Molnar, Ioana Chautard, Emmanuel Bernadach, Maureen Kossai, Myriam Saroul, Nicolas Martin, F. Pham-Dang, Nathalie Lapeyre, Michel Biau, Julian Front Oncol Oncology BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focus on loco-regional patterns of failure. MATERIAL AND METHODS: Between 2011 and 2019, 167 patients were included (40% of oropharyngeal cancers, and 60% of oral cavity cancers). The median age was 60 years. There was 64.2% of stage IV cancers. All patients had both T and N surgery. 34% had a R1 margin, 42% had perineural invasion. 72% had a positive neck dissection and 42% extranodal extension (ENE). All patients were treated with VMAT with simultaneous integrated boost with three dose levels: 66Gy in case of R1 margin and/or ENE, 59.4-60Gy on the tumor bed, and 54Gy on the prophylactic areas. Concomittant cisplatin was administrated concomitantly when feasible in case of R1 and/or ENE. RESULTS: The 1- and 2-year loco-regional control rates were 88.6% and 85.6% respectively. Higher tumor stage (T3/T4), the presence of PNI, and time from surgery >45 days were significant predictive factors of worse loco-regional control in multivariate analysis (p=0.02, p=0.04, and p=0.02). There were 17 local recurrences: 11 (64%) were considered as infield, 4 (24%) as marginal, and 2 (12%) as outfield. There were 9 regional recurrences only, 8 (89%) were considered as infield, and 1 (11%) as outfield. The 1- and 2-year disease-free survival (DFS) rates were 78.9% and 71.8% respectively. The 1- and 2-year overall survival (OS) rates were 88.6% and 80% respectively. Higher tumor stage (T3/T4) and the presence of ENE were the two prognostic factors significantly associated with worse DFS and OS in multivariate analysis. CONCLUSION: Our outcomes for postoperative VMAT for oral cavity and oropharyngeal cancers are encouraging, with high rates of loco-regional control. However, the management of ENE still seems challenging. Frontiers Media S.A. 2023-10-31 /pmc/articles/PMC10644788/ /pubmed/38023128 http://dx.doi.org/10.3389/fonc.2023.1272856 Text en Copyright © 2023 Mione, Casile, Moreau, Miroir, Molnar, Chautard, Bernadach, Kossai, Saroul, Martin, Pham-Dang, Lapeyre and Biau https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Mione, Cécile Casile, Mélanie Moreau, Juliette Miroir, Jessica Molnar, Ioana Chautard, Emmanuel Bernadach, Maureen Kossai, Myriam Saroul, Nicolas Martin, F. Pham-Dang, Nathalie Lapeyre, Michel Biau, Julian Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title | Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title_full | Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title_fullStr | Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title_full_unstemmed | Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title_short | Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
title_sort | outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644788/ https://www.ncbi.nlm.nih.gov/pubmed/38023128 http://dx.doi.org/10.3389/fonc.2023.1272856 |
work_keys_str_mv | AT mionececile outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT casilemelanie outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT moreaujuliette outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT miroirjessica outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT molnarioana outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT chautardemmanuel outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT bernadachmaureen outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT kossaimyriam outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT saroulnicolas outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT martinf outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT phamdangnathalie outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT lapeyremichel outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy AT biaujulian outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy |